glp 1 ag GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1 and Dual GIP/GLP-1 Agonists

Similar findings have been observed in the arcuate nucleus (Abtahi et al., 2016)

What was known: GLP-1 receptor agonists and SGLT-2 inhibitors can modulate the gut microbiota, potentially contributing to their cardiovascular and renal protective effects beyond glucose lowering

Semaglutide binds to and activates GLP-1 receptors found predominantly in pancreatic beta cells, the brain, and the gastrointestinal tract

Curr Cardiovasc Risk Rep 19 , 18 (2025)

Compounded medications bypass patent-related costs, brand marketing expenses, and premium pricing structures associated with brand-name drugs

Therefore, a combination of GLP-1RAs with anticancer drugs could indirectly inhibit the migration, invasion, and growth of tumors by increasing the chemosensitivity of cancer cells